RespireRx Pharmaceuticals Inc.

CIK 849636 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for RespireRx Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2025REVOKED9999999997-25-003714
Feb 10, 20258-K0001493152-25-005521
Sep 6, 20248-K0001493152-24-035221
Aug 2, 20248-K0001493152-24-029979
Jul 8, 20248-K0001493152-24-026467
May 29, 20248-K0001493152-24-021733
Apr 16, 20248-K0001493152-24-014816
Apr 1, 2024NT 10-K0001493152-24-012350
Feb 2, 20248-K0001493152-24-004660
Jan 22, 20248-K0001493152-24-003131
Dec 11, 20238-K0001493152-23-044326
Nov 17, 202310-Q0001493152-23-041875
Nov 14, 2023NT 10-Q0001493152-23-041047
Oct 12, 20238-K0001493152-23-036993
Oct 2, 20238-K0001493152-23-034961
Aug 21, 202310-Q0001493152-23-029607
Aug 14, 2023NT 10-Q0001493152-23-028467
Aug 9, 20238-K0001493152-23-027277
Jun 13, 20238-K0001493152-23-021063
May 24, 20238-K0001493152-23-018786
May 22, 202310-Q0001493152-23-018545
May 15, 2023NT 10-Q0001493152-23-017301
May 5, 20238-K0001493152-23-015589
Apr 17, 202310-K0001493152-23-012542
Apr 13, 20238-K0001493152-23-012080